Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B at Birth Dose (Using Different Source of Hepatitis B), in Indonesian Infants

NCT04071379 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT04071379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04071379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B at Birth Dose (Using Different Source of Hepatitis B), in Indonesian Infants
Lead sponsor
PT Bio Farma
Phase
Phase 3
Overall status
Completed
Start date
October 13, 2020
Completion date
December 16, 2021
Enrollment
220 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

immunogenicity, safety